Oldest pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #1 to #50.
- Muscle-invasive Bladder Cancer (2017) (09:31, 14 December 2021)
- Open Radical Prostatectomy (09:57, 17 December 2021)
- Urothelial Cancer of the Prostate (10:00, 17 December 2021)
- Unresectable Locally Advanced and Metastatic Bladder Cancer (10:55, 17 December 2021)
- Segemental ureterectomy (15:35, 17 December 2021)
- Non-Germ Cell Tumours & Tumours of the Testicular Adnexa (11:44, 19 December 2021)
- Urethral Tumours (11:58, 19 December 2021)
- Ureters (12:10, 19 December 2021)
- Female Pelvis (13:17, 19 December 2021)
- Epididymis and Vas Deferens (13:46, 19 December 2021)
- Seminal Vesicles and Ejaculatory Ducts (13:48, 19 December 2021)
- Candiduria (18:57, 21 December 2021)
- CUA: Metastatic Castration-naive and Castration-sensitive Prostate Cancer (2020) (11:21, 22 March 2022)
- CUA: Prostate Cancer Screening (2017) (07:48, 23 March 2022)
- AUA: Clinically Localized Prostate Cancer (2017) (08:29, 23 March 2022)
- CUA: RCC Genetic Screening (2013) (12:28, 5 April 2022)
- Prostate Cancer: Pathology and TNM Staging (16:17, 5 April 2022)
- Adrenal Insufficiency (12:58, 29 September 2022)
- Adrenal: Benign Tumours (13:23, 29 September 2022)
- Retroperitoneal Fibrosis (19:46, 30 October 2022)
- Genitourinary Complications of Metabolic Syndrome (19:50, 30 October 2022)
- Renal Hypertension (19:56, 30 October 2022)
- Renal Transplant (20:05, 30 October 2022)
- Bladder and Testis Oncology (20:16, 30 October 2022)
- Pediatrics: Neuromuscular Disorders of the Lower Urinary Tract (07:27, 31 October 2022)
- Functional: Aging and Geriatric Urology (13:10, 4 November 2022)
- Infections: Clostridium Difficile Infection (13:22, 4 November 2022)
- CUA/AUA: Non-muscle Invasive Bladder Cancer (2021 CUA/2016 AUA)) (06:39, 11 November 2022)
- AUA: Surgical Management of LUTS due to BPH (2018) (13:11, 11 November 2022)
- CUA: Castrate-resistant Prostate Cancer (2021) (13:37, 11 November 2022)
- CUA: Androgen Deprivation Therapy: Adverse Events & Management (2021) (13:38, 11 November 2022)
- CUA: Testosterone Suppression (2018) (13:39, 11 November 2022)
- Cancer Care Ontario: MRI in Prostate Cancer Diagnosis (2017) (13:40, 11 November 2022)
- CUA: Advanced and Metastatic Urothelial Cancer (2019) (13:40, 11 November 2022)
- CUA: Prostate Cancer Active Surveillance (2015) (13:41, 11 November 2022)
- CUA: Asymptomatic Microscopic Hematuria (2008) (13:44, 11 November 2022)
- CUA: Small Renal Masses (2015) (13:46, 11 November 2022)
- CUA: Surgical Management of RCC (2014) (13:46, 11 November 2022)
- CUA: Peyronie's Disease (2018) (13:47, 11 November 2022)
- CUA: Male LUTS & BPH (2018) (13:56, 11 November 2022)
- AUA: Prostate Cancer Screening (2018) (10:38, 4 January 2023)
- Scrotum & Spermatic Cord (18:30, 6 January 2023)
- Kidneys (21:32, 13 January 2023)
- Bladder (16:57, 19 January 2023)
- Orthotopic Urinary Diversion (18:35, 24 January 2023)
- CUA: Antibiotic Prophylaxis (2015) (13:48, 9 February 2023)
- CUA: Azoospermia (2015) (14:07, 9 February 2023)
- CUA: Circumcision (2018) (14:11, 9 February 2023)
- CUA: Cryptorchidism (2017) (14:23, 9 February 2023)
- CUA: Multicystic Dysplastic Kidney in the Neonate (2015) (14:25, 9 February 2023)